@FierceMedDev: ICYMI: Roche's Ventana to concoct companion Dx tests for Incyte's cancer drugs. More | Follow @FierceMedDev
@MarkHFierce: Biocept becomes the latest Dx company to outline its IPO terms - full speed ahead. Story | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Gold nanoparticles first to deliver RNA to brain tumors. More from FierceDrugDelivery | Follow @MichaelGFierce
> Smith & Nephew ($SNN) is beginning the U.S. rollout of a new suture anchor for arthroscopic surgery that's made of a biocomposite material absorbed into the body within two years. Release
> A judge declared a mistrial in a malpractice case against a former Maryland cardiologist and the former owners of St. Joseph Medical Center that alleged the unnecessary use of stents that injured a patient. Story
> Surgical device maker Globus Medical faces an FDA warning letter for alleged quality system and medical device reporting violations at its Audubon, PA, facility. Warning letter
> Kips Bay Medical, a maker of vein support devices for coronary artery bypass grafting surgery, lost $1.6 million in the 2013 quarter, versus a $1.4 million net loss over the same period in 2012. Release
> Veniti gained a CE mark for two products: its Vici venous stent to treat blocked veins, and a new varicose vein ablation device. Release
> Cantel Medical ($CMN) snatched up an Israeli company that developed a device to help improve colonoscopy procedures. Story
Biotech News
@FierceBiotech: Novartis R&D will ax 500 staffers, boost Boston in global realignment. More | Follow @FierceBiotech
@JohnCFierce: Geron shares double on imetelstat data. Quite a reversal of fortune for Geron. Story | Follow @JohnCFierce
@DamianFierce: Medtronic wins FDA approval to use its software with competitors' tech. More | Follow @DamianFierce
@EmilyMFierce: Next Generation: Cancer Drug in Disguise. Article | Follow @EmilyMFierce
> Shire slashes R&D ops, refocuses pipeline as it restructures in Europe, U.S. News
> GlaxoSmithKline toes the line in Breo launch. Item
Pharma News
@FiercePharma: Biggest new news online: Will Merck be next to join Big Pharma's asset sale parade? Story | Follow @FiercePharma
@CarlyHFierce: Does the Justice Department's off-label marketing enforcement actually deter bad behavior? With GSK, maybe. More | Follow @CarlyHFierce
> J&J whistleblowers to collect record $168M share of DoJ settlement. Story
> Roche's new Gazyva beats predecessor Rituxan in staving off CLL. News
> Top Adcock shareholder nixes CFR offer, endangering $1.3B deal. More
Pharma Manufacturing News
> Hospira CEO looks to better days as 'swamp draining' nears end. News
> Wholesaler McKesson settles another price-manipulation suit. Article
> FDA finally lifts warning letter on AMRI fill/finish facility. More
> Visa woes still stalling FDA plans for China inspections. Story
> Pfizer contractors testing new methods to clean up old production site. News
> Nosco hiring 51 staff for packaging and labeling plant. Item
Vaccines News
> Merck readies FDA submission for son of Gardasil. News
> Takeda, Boehringer invest to move CMV vaccine into clinic. Story
> European scientists join Sanofi, Pfizer in C. diff vaccine race. Article
> Study finds one HPV vaccine dose gives strong, durable immune response. News
> WHO massively scales up Middle East polio immunization plan. Story
> Shipping snafu prompts Navy review of vaccination procedures. Item